el-Din M A, Palmer L B, el-Tayeb M N, Khalil I, Gabr M S
Chest Department, Ain Shams University, Abassia, Cairo, Egypt.
J Aerosol Med. 1994 Winter;7(4):345-50. doi: 10.1089/jam.1994.7.345.
Aerosolized antibiotics have been shown to be a useful modality of treatment in patients with cystic fibrosis. In this investigation we examined the utility of this treatment in patients with other chronic suppurative lung disorders. These included forty patients, thirty men and ten women with chronic airway infection (27 with bronchiectasis, 6 with chronic abscess and 7 with chronic suppurative bronchitis). Pathogenic organisms were isolated from the affected part of the lung by a fiberoptic bronchoscopy using a sterile disposable bronchial microbiology brush. Cultures from these specimens were used to determine the appropriate antibiotic. A second control group of 20 patients was treated with systemic antibiotics alone. Both systemic and aerosolized antibiotics were administered in 20 patients. A statistically significant improvement in clinical, and ventilatory functions was recorded in the first group compared to the second. Nebulized antibiotics used as adjunctive therapy in association with systemic antibiotics may offer a therapeutic advantage in chronic suppurative lung diseases.
雾化抗生素已被证明是治疗囊性纤维化患者的一种有效方法。在本研究中,我们检查了这种治疗方法对其他慢性化脓性肺部疾病患者的效用。这些患者包括40例,其中30名男性和10名女性患有慢性气道感染(27例支气管扩张、6例慢性脓肿和7例慢性化脓性支气管炎)。通过使用无菌一次性支气管微生物刷的纤维支气管镜从肺部受影响部位分离出致病微生物。这些标本的培养物用于确定合适的抗生素。第二组20名患者仅接受全身抗生素治疗。20名患者同时接受全身和雾化抗生素治疗。与第二组相比,第一组在临床和通气功能方面有统计学上的显著改善。雾化抗生素与全身抗生素联合用作辅助治疗可能在慢性化脓性肺部疾病中具有治疗优势。